Vicarious Surgical Executive to Sell 223 Shares Worth $1,780 on NYSE

Vicarious Surgical (NYSE: RBOT) insider filing reveals planned sale of 223 shares of Class A Common Stock with an aggregate market value of $1,779.54.

Rhea-AI Filing Summary

Vicarious Surgical (NYSE: RBOT) insider filing reveals planned sale of 223 shares of Class A Common Stock with an aggregate market value of $1,779.54. The sale is scheduled for June 23, 2025, through UBS Financial Services.

The shares being sold were acquired on June 20, 2025, through a Restricted Stock Lapse of 694 shares. The seller, who has recent trading history, previously sold:

• 653 shares on May 20, 2025 (proceeds: $4,748)
• 239 shares on June 3, 2025 (proceeds: $1,641)

The filing indicates there are 5,277,994 shares outstanding. This Form 144 represents a notice of proposed sale of securities acquired through equity compensation, demonstrating ongoing insider transactions while maintaining regulatory compliance under Rule 144 of the Securities Act.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares of RBOT stock are being sold according to the Form 144 filing from June 2025?

According to the Form 144 filing, 223 shares of RBOT Class A Common Stock are proposed to be sold through UBS Financial Services Inc, with an aggregate market value of $1,779.54.

What is the total number of RBOT shares outstanding as of June 2025?

According to the Form 144 filing, Vicarious Surgical Inc. (RBOT) had 5,277,994 shares outstanding at the time of the filing.

How did the seller acquire the RBOT shares being sold?

The shares were acquired through a Restricted Stock Lapse on June 20, 2025, where 694 shares of Class A Common Stock were acquired from Vicarious Surgical Inc.

What previous RBOT stock sales were made by the seller in the past 3 months?

The seller, Sammy Khalifa of Waltham MA, made two previous sales: 653 shares on May 20, 2025, with gross proceeds of $4,748, and 239 shares on June 3, 2025, with gross proceeds of $1,641.

When is the approximate date of sale for the RBOT shares mentioned in this Form 144?

The approximate date of sale for the RBOT shares is listed as June 23, 2025, and the shares will be sold on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/23/2025 - 12:37 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001883777
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vicarious Surgical Inc
SEC File Number	001-39384
Address of Issuer	78 4th Ave Waltham MASSACHUSETTS 02451
Phone	6178681700
Name of Person for Whose Account the Securities are To Be Sold	Sammy Khalifa
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	223	1779.54	5277994	06/23/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	06/20/2025	Restricted Stock Lapse	Vicarious Surgical Inc			694	06/20/2025	Restricted Stock Lapse

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Sammy Khalifa 78 4th Ave Waltham MA 02451	Class A Common Stock	05/20/2025	653	4748
Sammy Khalifa 78 4th Ave Waltham MA 02451	Class A Common Stock	06/03/2025	239	1641

144: Remarks and Signature

Remarks
Date of Notice	06/23/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/JOSEPH CASSIDY, as a duly authorized representative of UBS Financial Services Inc, as attorney-in-fact for Sammy Khalifa
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)